Non-Steroidal Anti-Inflammatory Drugs Market, By Indication (Arthritis, Migraine, Ophthalmic Disease...
Market Size in USD Bn
CAGR5.9%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 5.9% |
Market Concentration | High |
Major Players | Pfizer Inc., Johnson & Johnson Services, Inc., Bayer AG, Sanofi, GSK plc and Among Others |
The non-steroidal anti-inflammatory drugs market is estimated to be valued at USD 25.84 Bn in 2025 and is expected to reach USD 38.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032. The market has been observing steady growth over the past few years driven by rising geriatric population and increasing prevalence of arthritis disorders worldwide.